9月4日，博苑股份跌5.72%，成交额4.84亿元。两融数据显示，当日博苑股份获融资买入额2775.30万 元，融资偿还9964.02万元，融资净买入-7188.72万元。截至9月4日，博苑股份融资融券余额合计1.18亿 元。 融资方面，博苑股份当日融资买入2775.30万元。当前融资余额1.18亿元，占流通市值的5.84%。 截至8月29日，博苑股份股东户数9715.00，较上期减少26.59%；人均流通股3439股，较上期增加 36.22%。2025年1月-6月，博苑股份实现营业收入7.47亿元，同比增长7.39%；归母净利润9904.29万元， 同比减少19.09%。 分红方面，博苑股份A股上市后累计派现8840.80万元。 责任编辑：小浪快报 融券方面，博苑股份9月4日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元。 资料显示，山东博苑医药化学股份有限公司位于山东省寿光市侯镇海洋化工园区新海路与大九路路口北 200米，成立日期2008年8月6日，上市日期2024年12月11日，公司主营业务涉及专业从事精细化学品研 发、生产、销售及 ...

Summary of Key Points Core Viewpoint - The latest financing balance of the ChiNext market is 469.46 billion yuan, showing a decrease of 3.18 billion yuan compared to the previous period, with 17 stocks experiencing a financing balance growth of over 10% and 23 stocks seeing a decline of over 10% [1]. Financing Balance Overview - As of September 4, the ChiNext index fell by 4.25%, with a total margin balance of 470.97 billion yuan, a decrease of 3.25 billion yuan from the previous trading day. The financing balance is 469.46 billion yuan, down by 3.18 billion yuan, while the securities lending balance is 1.51 billion yuan, down by 64.33 million yuan [1]. - Among the 445 stocks with increased financing balances, 17 stocks saw an increase of over 10%. The largest increase was for Shangneng Electric, with a financing balance of 738.61 million yuan, up by 60.76% [1][3]. Stocks with Increased Financing Balances - The stocks with the highest financing balance increases include: - Shangneng Electric: 738.61 million yuan, +60.76%, closing price 34.12 yuan, +13.32% [3]. - Baipusais: 94.00 million yuan, +18.99%, closing price 60.40 yuan, -7.79% [3]. - Kailong Gaoke: 46.23 million yuan, +16.27%, closing price 15.29 yuan, +0.92% [3]. - The average increase for stocks with over 10% growth was 1.22%, with notable performers including Shangneng Electric, Pinwo Food, and Penghui Energy [1]. Stocks with Decreased Financing Balances - A total of 498 stocks saw a decrease in financing balances, with 23 stocks experiencing a decline of over 10%. The largest decrease was for Boyuan Shares, with a financing balance of 11.83 million yuan, down by 37.80% [4]. - Other significant declines include: - Songsheng Shares: 7.55 million yuan, -32.62% [4]. - Youyou Green Energy: 11.74 million yuan, -30.99% [4]. Capital Flow Analysis - On September 4, among the stocks with increased financing balances, 11 stocks saw net inflows of main funds, with Penghui Energy and Shangneng Electric leading with net inflows of 139 million yuan and 133 million yuan, respectively [2]. - Conversely, six stocks experienced net outflows, with Xian Dao Intelligent and Baipusais seeing the largest outflows of 192 million yuan and 22.51 million yuan, respectively [2].

Group 1 - The company announced the convening of its first employee representative meeting for 2025 on September 4, 2025 [1] - During the meeting, the representatives democratically discussed and approved the proposal to elect the second employee representative director for the company's board [1] - Mr. Yu Fuqiang was elected as the second employee representative director, with his term starting from the approval date until the end of the second board's term [1]

Summary of Key Points Core Viewpoint The recent data indicates a significant decline in the number of shareholders for many companies, with 310 out of 564 companies reporting a decrease in shareholder count as of August 31. This trend raises questions about investor sentiment and market performance. Group 1: Shareholder Count Changes - A total of 564 companies disclosed their shareholder counts as of August 31, with 310 showing a decrease compared to the previous period [1][3]. - Among the companies with a decline in shareholder count, 48 experienced a drop of over 10% [3]. - The largest decrease was reported by Boyuan Co., with a 26.59% drop in shareholder count, totaling 9,715 shareholders [3]. Group 2: Market Performance of Concentrated Stocks - The concentrated stocks monitored from August 11 to August 20 showed an average decline of 0.87%, underperforming the Shanghai Composite Index, which rose by 3.60% during the same period [2]. - Despite the overall decline, 21% of the concentrated stocks outperformed the market, indicating some resilience among select companies [2]. - Among the stocks with a significant drop in shareholder count, Anpeilong saw the highest increase in share price, rising by 35.37% since August 11 [2]. Group 3: Industry Insights - The industries with the highest concentration of stocks experiencing shareholder count declines include machinery, basic chemicals, and electric equipment, with 42, 34, and 26 companies respectively [3]. - The performance of concentrated stocks varied significantly, with notable gains in companies like Guoguang Chain, Boyuan Co., and Hongsheng Co., which saw increases of 60.57%, 49.53%, and 26.75% respectively [3].

证券代码：301617 证券简称：博苑股份 公告编号：2025-046 山东博苑医药化学股份有限公司 关于选举第二届董事会职工代表董事的公告 2025 年 9 月 4 日 附件：职工代表董事简历 于福强先生，1971 年出生，中国国籍，无境外永久居留权，本科学历。1991 年 12 月至 2007 年 9 月，就职于山东大成农药股份有限公司，任工厂职员；2007 年 10 月至 2008 年 5 月，为自由职业者；2008 年 5 月至 2008 年 8 月，参与筹建 寿光博苑精细化工有限公司；2008 年 8 月至 2020 年 9 月，任寿光博苑精细化工 有限公司行政管理部经理；2020 年 9 月至今，任山东博苑医药化学股份有限公 司工程项目部总监。曾任山东博苑医药化学股份有限公司监事；现兼任潍坊智硕 投资合伙企业（有限合伙）执行事务合伙人。 截至本公告披露日，于福强先生通过潍坊智硕投资合伙企业（有限合伙）间 接持有公司 0.48%的股份，与公司其他董事、高级管理人员、实际控制人及持有 公司 5%以上有表决权股份的其他股东之间不存在关联关系；未受过中国证监会 及其他有关部门的处罚和证券交易所的纪律处分； ...

北京国枫律师事务所 关于山东博苑医药化学股份有限公司 2025 年第三次临时股东会的 法律意见书 国枫律股字[2025]A0411 号 致：山东博苑医药化学股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2025 年第三次临时股东会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称 "《股东会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证券法律 业务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简称"《证券法 律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《山东博苑医药化学 股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会议的召集与召开程 序、召集人资格、出席会议人员资格、会议表决程序及表决结果等事宜，出具本法律意 见书。 对本法律意见书的出具，本所律师特作如下声明： 北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/ ...

证券代码：301617 证券简称：博苑股份 公告编号：2025-045 山东博苑医药化学股份有限公司 2025 年第三次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会无变更、否决提案的情形； 2、本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间：2025 年 9 月 4 日（星期四）15:00 2、会议召开形式：采取现场投票和网络投票相结合的方式 3、会议召开地点：山东省寿光市侯镇海洋化工园区新海路与大九路路口北 200 米山东博苑医药化学股份有限公司会议室 4、网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间 为：2025 年 9 月 4 日上午 9:15-9:25，9:30-11:30，下午 13:00-15:00；通过深 圳证券交易所互联网投票系统投票的具体时间为：2025 年 9 月 4 日 9:15—15:00 期间的任意时间。 5、会议召集人：公司第二届董事会 6、会议主持人：公司董事长李成林先生 7、本次会议的召集、召开符合有关 ...

Group 1 - A total of 468 stocks reported their latest shareholder numbers as of August 31, with 260 stocks showing a decrease compared to the previous period [1][3] - The stocks with the largest decline in shareholder numbers include Boyuan Co., Yalian Machinery, and Feilong Co., with Boyuan Co. experiencing a 26.59% drop [3][4] - The average decline in shareholder numbers for the latest concentrated stock group was 4.26% since August 21, with 21% of these stocks outperforming the Shanghai Composite Index [2][3] Group 2 - Among the stocks with a decline of over 10% in shareholder numbers, Boyuan Co. had the highest increase in stock price, rising 58.61% since the concentration of shares [3][4] - Yalian Machinery reported a 25.51% decrease in shareholder numbers, with a slight increase of 1.93% in stock price during the same period [3][4] - The concentrated stocks are primarily found in the machinery, basic chemicals, and power equipment industries, with 38, 24, and 24 stocks respectively [3][4]

311只股公布截至8月31日最新股东户数，相比上期股东户数下降的有177只，降幅居前的是博苑股份、 亚联机械、飞龙股份等。 投资者除了在定期报告中获得股东信息数据外，还可以在交易所互动平台上通过提问方式了解部分公司 更及时（每月10日、20日、月末）的股东户数信息。以往3期分别有744家、879家、1130家公司在互动 平台透露了股东户数，截至发稿，共有311家公司公布了截至8月31日股东户数。 上期筹码集中股回测：21%跑赢沪指 其次是亚联机械，截至8月31日最新股东户数为7337户，较8月20日下降25.51%，筹码集中以来该股累 计上涨4.74%，累计换手率为129.61%，其间主力资金净流出2258.80万元。 市场表现方面，最新一期筹码集中股8月21日以来平均下跌1.50%，涨幅居前的有博苑股份、国光连 锁、震裕科技等，分别上涨64.31%、37.82%、31.02%。所属行业来看，筹码集中股中机械设备、电力 设备、基础化工等行业最为集中，分别有26只、17只、17只个股上榜。（数据宝） 最新筹码集中股排行榜 | 代码 | 简称 | 最新股东户数 | 较上期增减（%） | 筹码集中以来涨跌（%） | ...

Group 1: Company Overview - The company is Shandong Boyuan Pharmaceutical Chemical Co., Ltd., with stock code 301617 and abbreviation Boyuan Co. [1] - The company specializes in iodine and iodine derivatives, which are essential raw materials in various fields including medicine, agriculture, and industry [2][4]. Group 2: Iodine Market Insights - Iodine and its derivatives are widely used in X-ray contrast agents, disinfectants, and LCD screen polarizers, with the three core applications accounting for approximately 63% of global consumption [2][3]. - Major iodine production is concentrated in Chile, Japan, and the United States, which together account for 88% of global sales, with Chilean companies alone contributing about 60% [2][3]. Group 3: Product Portfolio - The company’s inorganic iodide products include potassium iodide, potassium iodate, sodium iodide, and hydrogen iodide, primarily used in pharmaceuticals, pesticides, and optical materials [4]. - The company also produces trimethyl iodide silane, used as a functional group protecting agent in organic synthesis, particularly in antibiotic production [4]. Group 4: Competitive Advantages - **Circular Development and Comprehensive Service**: The company integrates resource recycling with its main business, ensuring stable supply and low costs through waste material recovery [5]. - **Research and Development Strength**: The company has a professional R&D team with over 30 years of industry experience and has obtained 51 patents as of June 30, 2025 [5]. - **Industry Position**: The company maintains a leading market position in iodides and luminescent materials, with products recognized for their quality and performance [5][6]. - **Quality Control and Customer Relationships**: A comprehensive quality control system ensures high-quality products, fostering long-term partnerships with well-known clients [6]. - **Compliance and Safety**: The company adheres to strict compliance standards, holding all necessary safety and environmental permits, which enhances customer trust [6]. Group 5: Industry Standards and Influence - The company has participated in the formulation of 3 industry standards and 12 group standards, reflecting its influence and technical authority in the industry [6].